MeVis Medical Solutions AG (M3V) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.005x

Based on the latest financial reports, MeVis Medical Solutions AG (M3V) has a cash flow conversion efficiency ratio of 0.005x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€96.63K ≈ $112.97K USD) by net assets (€17.83 Million ≈ $20.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MeVis Medical Solutions AG (M3V) market capitalisation for the company's overall valuation and market capitalisation.

MeVis Medical Solutions AG - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how MeVis Medical Solutions AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

MeVis Medical Solutions AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MeVis Medical Solutions AG ranked by their cash flow conversion efficiency. Explore how high is MeVis Medical Solutions AG's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
OS Therapies Incorporated NYSE MKT:OSTX	-1.000x
Amicogen Inc KQ:092040	-0.027x
JSS Real Estate SOCIMI SA MC:YJSS	0.002x
Schwälbchen Molkerei Jakob Berz AG F:SMB	N/A
GenMont Biotech Inc TW:3164	0.011x
Oceanpal Inc NASDAQ:OP	-0.007x
Adaptimmune Therapeutics plc F:473A	0.490x
Next Bt Co. Ltd KQ:065170	-0.031x

Annual Cash Flow Conversion Efficiency for MeVis Medical Solutions AG (2006–2025)

The table below shows the annual cash flow conversion efficiency of MeVis Medical Solutions AG from 2006 to 2025. View M3V live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	€17.83 Million ≈ $20.84 Million	€3.88 Million ≈ $4.54 Million	0.218x	+23.29%
2024-09-30	€17.83 Million ≈ $20.84 Million	€3.15 Million ≈ $3.68 Million	0.177x	-46.25%
2023-09-30	€17.83 Million ≈ $20.84 Million	€5.85 Million ≈ $6.84 Million	0.328x	+20.52%
2022-09-30	€17.83 Million ≈ $20.84 Million	€4.86 Million ≈ $5.68 Million	0.272x	-46.80%
2021-09-30	€17.83 Million ≈ $20.84 Million	€9.13 Million ≈ $10.68 Million	0.512x	+215.97%
2020-09-30	€17.83 Million ≈ $20.84 Million	€2.89 Million ≈ $3.38 Million	0.162x	-55.84%
2019-09-30	€17.83 Million ≈ $20.84 Million	€6.54 Million ≈ $7.65 Million	0.367x	+113.19%
2018-09-30	€32.06 Million ≈ $37.48 Million	€5.52 Million ≈ $6.45 Million	0.172x	-23.55%
2017-09-30	€32.51 Million ≈ $38.01 Million	€7.32 Million ≈ $8.56 Million	0.225x	+111.15%
2016-09-30	€32.89 Million ≈ $38.45 Million	€3.51 Million ≈ $4.10 Million	0.107x	-45.32%
2015-09-30	€33.73 Million ≈ $39.43 Million	€6.58 Million ≈ $7.69 Million	0.195x	+22.25%
2014-09-30	€30.27 Million ≈ $35.39 Million	€4.83 Million ≈ $5.65 Million	0.160x	-43.60%
2013-09-30	€26.45 Million ≈ $30.92 Million	€7.48 Million ≈ $8.75 Million	0.283x	+21.84%
2012-09-30	€22.77 Million ≈ $26.62 Million	€5.29 Million ≈ $6.18 Million	0.232x	-5.73%
2011-09-30	€20.73 Million ≈ $24.23 Million	€5.11 Million ≈ $5.97 Million	0.246x	+23.38%
2010-09-30	€24.79 Million ≈ $28.98 Million	€4.95 Million ≈ $5.79 Million	0.200x	+112.02%
2009-09-30	€32.61 Million ≈ $38.12 Million	€3.07 Million ≈ $3.59 Million	0.094x	+5.62%
2008-09-30	€32.61 Million ≈ $38.13 Million	€2.91 Million ≈ $3.40 Million	0.089x	+211.17%
2007-09-30	€30.77 Million ≈ $35.97 Million	€-2.47 Million ≈ $-2.89 Million	-0.080x	-104.63%
2006-09-30	€2.65 Million ≈ $3.10 Million	€4.59 Million ≈ $5.37 Million	1.732x	--

About MeVis Medical Solutions AG

XETRA:M3V Germany Health Information Services

Market Cap

$49.79 Million

€42.59 Million EUR

Market Cap Rank

#22552 Global

#1979 in Germany

Share Price

€23.40

Change (1 day)

+1.74%

52-Week Range

€22.20 - €26.40

All Time High

€35.79